New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states.
Looking at a per-day basis, sales decreased sequentially in 9 out of 11 states according to cannabis data analytics firm BDSA. Compared to a year ago, sales were down in 7 markets, mostly driven by declining flower growth. In this review, we will look at the markets one-by-one, beginning with the eastern markets and then concluding with the western markets. In total, sales across the 11 markets totaled $1.66 billion during the month.
Eastern Markets
BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan and Pennsylvania. In May, year-over-year growth ranged from -10.2% in Maryland to 23.6% in Michigan. Note that Florida, Maryland and Pennsylvania are medical-only markets.
Florida
In May, sales remained flat sequentially at $186.4 million, up 23.6% from a year ago. Flower sales grew 28%, as pre-rolls increased 2%. Concentrates gained 30%. Ingestibles expanded 10%.
Illinois
We previously published data released by the state showing that sales declined 2.2% from April and increased 6.2% from May 2021. BDSA estimated sales of $159.9 million, down 2.2% sequentially and up 6.2% from a year ago. Compared to last year, flower sales expanded 2%. Pre-rolls gained 12% and ingestibles grew 1%, while concentrates increased 13%.
Maryland
Sales fell 4.5% from April to $42.3 million, down 10.2% from a year ago. Flower and concentrates sales decreased 12% and pre-rolls fell 13%, while ingestibles grew 5%.
Massachusetts
Sales declined 1.8% sequentially and increased 9% compared to a year ago to $144.1 million. Flower sales expanded 1%, pre-rolls jumped 44%, ingestibles increased 11% and concentrates grew 4%.
Michigan
We had previously written about data released by the state indicating that Michigan cannabis sales declined 4% sequentially and increased 25% year-over-year. BDSA estimated sales of $186.5 million, down 4.4% sequentially and up 23.6% from a year ago. Flower sales increased 21%, while concentrates grew 38%. Pre-rolls jumped 66% and ingestibles declined 7%.
Pennsylvania
Sales fell 5.6% in May to $96.3 million, down 7.6% compared to a year ago. Flower sales declined 5% year-over-year, concentrates fell 10%, while ingestibles decreased 3%.
Western Markets
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In May,, year-over-year growth ranged from -25.4% in Nevada to -10.2% in Arizona compared to a year ago.
Arizona
Combined sales of $108.9 million were down 3.1% from April and 10.2% compared to May 2021. Medical sales of $46.5 million were down 5% sequentially and 33% from a year ago. Adult-use sales of $62.3 million declined 2% from April and increased 19% year-over-year. Flower sales were down 21% from a year ago, while pre-rolls gained 36%. Concentrates fell 9% and ingestibles decreased 2%.
California
California sales increased 3.4% sequentially to $442.2 million and fell 7.6% compared to a year ago. Flower sales were down 16%, while pre-rolls grew 11%. Ingestibles fell 7% and concentrates dropped 5% from a year ago during May.
Colorado
Sales declined 11.9% in May compared to April, dropping 23.8% from a year ago to $147.8 million. Flower sales were down 30%, with pre-rolls and concentrates falling 18%. Ingestibles declined 22% year-over-year.
Nevada
Sales increased 15.8% sequentially, falling 25.4% from a year ago to $65.3 million. May flower sales dropped 37% from a year ago. Concentrates fell 11%, while ingestibles decreased 17% and pre-rolls declined 12%.
Oregon
Sales in May fell 5.8% from April to $84.7 million, down 19.9% from a year ago. Flower sales were down 32% year-over-year. Ingestibles grew 9%, while pre-rolls declined 6% and concentrates decreased 19%.
For readers interested in a deeper look at cannabis markets across these eleven states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with unlimited access to the most accurate and actionable data and analysis.
